Could a simple IV drug replace needles for knee surgery pain?
NCT ID NCT04828083
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving lidocaine through an IV works as well as an ultrasound-guided nerve block for controlling pain after total knee replacement. 120 adults having knee surgery were randomly assigned to receive either IV lidocaine or a saline placebo (with the nerve block group getting the opposite). The main goal was to see if IV lidocaine could reduce the amount of opioids needed after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- lidocaine
- What this could lead to
- If IV lidocaine works as well as a nerve block, it could offer a simpler, needle-free option for managing pain after knee replacement surgery.
- What could go wrong
- This is a small, completed Phase 4 trial with only 120 participants. The results may not apply to everyone, and IV lidocaine can have side effects like dizziness or heart issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
120 people
The number who actually took part.
- Started
-
Mar 2021
- Finished
-
Sep 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ASA PS 1-3 patients undergoing primary, unilateral total knee arthroplasty Exclusion Criteria: * ASA PS classification of 4 or greater * Pre-existing neuropathy * Coagulopathy * Chronic opioid consumption (\>3 months) * Infection at the site * Known allergy to study medications (lidocaine) * High grade atrioventricular block (cardiac conduction system impairment) * A history of CVA/TIA * Currently using lidocaine patches * Known liver disease
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthroplasty, replacement, knee are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What do knee replacement patients really need to know? a study asks them
- Prepping the knee before surgery: a new approach to better recovery
- Which nerve drug wins the battle against Post-Surgical knee pain?
- Knee replacement pain: can a simple injection match a nerve block?
- Can a single steroid dose transform knee replacement recovery?
- Which nerve block keeps you moving after knee surgery?